WeVote

Bill

Bill

SB 1554

Public Records/Experimental Treatment Outcomes

2026 Regular Session Introduced by Danny Burgess

SB 1554 establishes public records rules for experimental treatment outcome data in Florida, balancing medical privacy protections with transparency requirements.

Died in Health Policy
0
WeVote Research Nonpartisan
Bill Summary · SB 1554

Legislative bill overview

SB 1554 addresses public records access related to experimental treatment outcomes in Florida. The bill appears to establish parameters for how medical records and outcome data from experimental or investigational treatments are classified and disclosed under Florida's public records laws. It likely creates exemptions or special handling procedures for sensitive medical information while potentially requiring reporting of treatment efficacy data.

Why is this important

This bill balances transparency with medical privacy by determining what experimental treatment information becomes public record. The outcome affects patients' rights to privacy, healthcare providers' liability exposure, pharmaceutical companies' proprietary concerns, and public health agencies' ability to monitor experimental treatment safety and effectiveness.

Potential points of contention

  • Privacy vs. Transparency: Defining which experimental treatment outcomes should be public record versus protected health information, particularly when patients may not want their participation in experimental programs disclosed
  • Medical Innovation Impact: Whether excessive public disclosure requirements could discourage participation in clinical trials or slow medical innovation by exposing proprietary research data
  • Liability and Reporting: Balancing mandatory reporting of experimental treatment outcomes with providers' concerns about litigation exposure from unfavorable results, and whether negative outcomes must be publicly disclosed

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.